{"title":"激素替代疗法和心脏病:最新进展","authors":"P. Hannaford","doi":"10.1002/TRE.27","DOIUrl":null,"url":null,"abstract":"www.tugsh.com Trends in Urology Gynaecology & Sexual Health July/August 2007 At the start of this millennium, about a third of women in the UK aged 50–64 years were estimated to be current users of hormone replacement therapy (HRT), and 50 per cent ever-users.1 The popularity of this treatment was driven, in part, by evidence from observational studies suggesting substantial protection from coronary heart disease among HRT users, perhaps by about a third.2 Enthusiasm for such use, however, received a severe setback in 2003 when the Women’s Health Initiative (WHI) investigators announced that they were halting prematurely their randomised trial of oestrogen combined with progestogen.","PeriodicalId":178319,"journal":{"name":"Trends in Urology, Gynaecology & Sexual Health","volume":"103 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2007-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"HRT and heart disease: an update\",\"authors\":\"P. Hannaford\",\"doi\":\"10.1002/TRE.27\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"www.tugsh.com Trends in Urology Gynaecology & Sexual Health July/August 2007 At the start of this millennium, about a third of women in the UK aged 50–64 years were estimated to be current users of hormone replacement therapy (HRT), and 50 per cent ever-users.1 The popularity of this treatment was driven, in part, by evidence from observational studies suggesting substantial protection from coronary heart disease among HRT users, perhaps by about a third.2 Enthusiasm for such use, however, received a severe setback in 2003 when the Women’s Health Initiative (WHI) investigators announced that they were halting prematurely their randomised trial of oestrogen combined with progestogen.\",\"PeriodicalId\":178319,\"journal\":{\"name\":\"Trends in Urology, Gynaecology & Sexual Health\",\"volume\":\"103 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2007-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Trends in Urology, Gynaecology & Sexual Health\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1002/TRE.27\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Trends in Urology, Gynaecology & Sexual Health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/TRE.27","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
www.tugsh.com Trends in Urology Gynaecology & Sexual Health July/August 2007 At the start of this millennium, about a third of women in the UK aged 50–64 years were estimated to be current users of hormone replacement therapy (HRT), and 50 per cent ever-users.1 The popularity of this treatment was driven, in part, by evidence from observational studies suggesting substantial protection from coronary heart disease among HRT users, perhaps by about a third.2 Enthusiasm for such use, however, received a severe setback in 2003 when the Women’s Health Initiative (WHI) investigators announced that they were halting prematurely their randomised trial of oestrogen combined with progestogen.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
